Vaxxinity issues shareholder letter

Cape canaveral, fla., april 19, 2024 (globe newswire) -- vaxxinity, inc. (“vaxxinity”, “we”, “us” or the “company”) (nasdaq: vaxx), a u.s. company pioneering the development of a new class of medicines, today announced issued a letter to shareholders from its co-founder and executive chairman, lou reese and chief executive officer, mei mei hu.
VAXX Ratings Summary
VAXX Quant Ranking